de Bruijn HW - Search Results

1

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.

Duk JM, de Bruijn HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, Aalders JG. Duk JM, et al. Among authors: de bruijn hw. Gynecol Oncol. 1990 Nov;39(2):186-94. doi: 10.1016/0090-8258(90)90430-s. Gynecol Oncol. 1990. PMID: 2227594

2

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.

Pras E, Willemse PH, Canrinus AA, de Bruijn HW, Sluiter WJ, ten Hoor KA, Aalders JG, Szabo BG, de Vries EG. Pras E, et al. Among authors: de bruijn hw. Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):23-32. doi: 10.1016/s0360-3016(01)01805-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 11777619

3

The effect of abdominal surgery on the serum concentration of the tumour-associated antigen CA 125.

van der Zee AG, Duk JM, Aalders JG, Boontje AH, ten Hoor KA, de Bruijn HW. van der Zee AG, et al. Among authors: de bruijn hw. Br J Obstet Gynaecol. 1990 Oct;97(10):934-8. doi: 10.1111/j.1471-0528.1990.tb02450.x. Br J Obstet Gynaecol. 1990. PMID: 2223686

4

Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.

Aalders JG, de Bruijn HW, Oosterhuis JW, Duk JM. Aalders JG, et al. Among authors: de bruijn hw. Gynecol Oncol. 1990 Jan;36(1):110-2. doi: 10.1016/0090-8258(90)90119-6. Gynecol Oncol. 1990. PMID: 2295441 No abstract available.

5

Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.

Duk JM, De Bruijn HW, Groenier KH, Fleuren GJ, Aalders JG. Duk JM, et al. Among authors: de bruijn hw. Cancer. 1990 Apr 15;65(8):1830-7. doi: 10.1002/1097-0142(19900415)65:8<1830::aid-cncr2820650828>3.0.co;2-s. Cancer. 1990. PMID: 2317761

6

Serum CA 125 levels in patients with a provisional diagnosis of pelvic inflammatory disease. Clinical and theoretical implications.

Duk JM, Kauer FM, Fleuren GJ, de Bruijn HW. Duk JM, et al. Among authors: de bruijn hw. Acta Obstet Gynecol Scand. 1989;68(7):637-41. doi: 10.3109/00016348909013284. Acta Obstet Gynecol Scand. 1989. PMID: 2631530

7

Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.

Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW. Duk JM, et al. Among authors: de bruijn hw. Obstet Gynecol. 1989 Apr;73(4):661-8. Obstet Gynecol. 1989. PMID: 2648225

8

Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin.

Duk JM, van Voorst Vader PC, ten Hoor KA, Hollema H, Doeglas HM, de Bruijn HW. Duk JM, et al. Among authors: de bruijn hw. Cancer. 1989 Oct 15;64(8):1652-6. doi: 10.1002/1097-0142(19891015)64:8<1652::aid-cncr2820640816>3.0.co;2-m. Cancer. 1989. PMID: 2790678

9

Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva.

van der Sijde R, de Bruijn HW, Krans M, Bouma J, Aalders JG. van der Sijde R, et al. Among authors: de bruijn hw. Gynecol Oncol. 1989 Nov;35(2):227-32. doi: 10.1016/0090-8258(89)90049-8. Gynecol Oncol. 1989. PMID: 2807015

10

Cell biological markers of drug resistance in ovarian carcinoma.

van der Zee AG, Hollema HH, de Bruijn HW, Willemse PH, Boonstra H, Mulder NH, Aalders JG, de Vries EG. van der Zee AG, et al. Among authors: de vries eg, de bruijn hw. Gynecol Oncol. 1995 Aug;58(2):165-78. doi: 10.1006/gyno.1995.1205. Gynecol Oncol. 1995. PMID: 7622101 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters